|
|
Build Your Online Product Catalogs?
| Product Name: |
coluracetam
|
| Supply Ability: |
|
| Related proudcts |
coluracetam, 135463-81-9, |
| Specifications |
99% |
| Price Term: |
CIF |
| Port of loading: |
Shanghai |
| Minimum Order |
1g |
| Unit Price: |
1 |
|
Coluracetam (INN) (code name BCI-540; formerly MKC-231) is a nootropic agent of the racetam family. It was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depressive disorder (MDD), which was preceded by being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California. Findings from phase IIa clinical trials have suggested that it would be a potential medication for comorbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently [when?] out-licensing the drug for this purpose. [full citation needed] It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.[medical citation needed]
Coluracetam has been shown to reverse the loss of choline acetyltransferase production in the medial septal nucleus of rats exposed to phencyclidine (***), and is considered a potential therapeutic drug for schizophrenia
|
| Company: |
Shanghai Angewchem Co.Ltd
|
| Contact: |
Mr. Dylan Zhang |
| Address: |
:No. 3377, Kang Xin Road, Pudong New Area, Shanghai |
| Postcode: |
201200 |
| Tel: |
+86-21-50762507 |
| Fax: |
18917157435 |
| E-mail: |
|
|
|
|
Home
